-
COVID-19: UK commits £210m as pharmacist warns Brits not to stockpile Ventolin inhalers
pharmatimes
March 30, 2020
Amidst the growing “unprecedented circumstances”, the UK government has said it will contribute £210 million toward international efforts aimed at finding a vaccine against the novel virus.
-
ClinOne’s remote clinical trial patient management technology allows pharmaceutical companies to continue clinical research efforts amidst Covid-19 pandemic in accordance with FDA guidelines
pharmaceutical-business-review
March 30, 2020
The Covid-19 pandemic has shined a bright light on the need to manage patients remotely wherever possible.
-
FDA Takes Action to Increase U.S. Supplies through Instructions for PPE, Device Manufacturers
americanpharmaceuticalreview
March 30, 2020
The U.S. Food and Drug Administration (FDA) took action to increase U.S. supplies to support the U.S. response to COVID-19 by providing instructions to manufacturers importing personal protective equipment and other devices.
-
Italian Researchers Identify New SARS-CoV-2 Gene Variants
americanpharmaceuticalreview
March 30, 2020
Two teams of infectious disease researchers in Italy say they have further analyzed the SARS-CoV-2 genome from samples acquired locally to generate early data.
-
Partner Therapeutics Announces Trial to Evaluate Leukine® for COVID-19 Respiratory Illness
americanpharmaceuticalreview
March 30, 2020
Partner Therapeutics announced Leukine® (sargramostim, rhu-GM-CSF) is being assessed in the SARPAC trial (sargramostim in patients with acute hypoxic respiratory failure due to COVID-19 – EudraCT #2020-001254-22).
-
95 percent of pharma industry concerned about COVID-19 impact, finds survey
europeanpharmaceuticalreview
March 30, 2020
The survey indicates that almost all respondents were concerned about the COVID-19 pandemic’s effects on company performance, including supply and demand failures.
-
Biopharma industry leaders collaborate to combat COVID-19
europeanpharmaceuticalreview
March 30, 2020
The International Federation of Pharmaceutical Manufacturers and Associations has announced that the biopharma industry has responding swiftly to the COVID-19 pandemic and will further increase its efforts.
-
Novartis partners with life sciences companies to fight Covid-19
pharmaceutical-technology
March 30, 2020
Novartis has partnered with a consortium of life sciences companies to rapidly develop, produce and deliver vaccines, diagnostics and treatments for Covid-19 coronavirus infection.
-
Sanofi and Translate Bio to develop mRNA vaccine for Covid-19
pharmaceutical-technology
March 30, 2020
Sanofi vaccines division Sanofi Pasteur has partnered with Translate Bio for the development of a messenger RNA (mRNA) vaccine against Covid-19.
-
UK pledges £210m to CEPI for Covid-19 vaccine development
pharmaceutical-technology
March 30, 2020
Non-profit the Coalition for Epidemic Preparedness Innovations (CEPI) has received £210m from the UK Government to support efforts to develop a Covid-19 vaccine.